Author details

Ishaq N. Khan1,3, Wafaa S. Ramadan2,6\*, Ghada A. Abdel-Hamid2,7, Saleh Al Karim3,4 and Habiba Aurangzeb4,5

[7] White N-H, Black N-H. Spinal Cord Injury (SCI) Facts and Figures at a Glance. National

Cellular Transplantation-Based Therapeutic Strategies for Spinal Cord Injuries: Preclinical and Clinical…

http://dx.doi.org/10.5772/intechopen.73220

145

[8] Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurgical

[9] Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: A nugget of this multiply cascade. Acta Neurobiologiae Experimentalis (Wars). 2011;71(2):281-299 [10] Akdemir H, Pasaoĝlu A, Öztürk F, Selçuklu A, Koç K, Kurtsoy A. Histopathology of experimental spinal cord trauma. Research in Experimental Medicine. 1992;192(1):177-183

[11] Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. Journal of Neurosurgery. 1991;75(1):15-26

[12] Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat.

[13] Xu G-Y, Hughes MG, Zhang L, Cain L, McAdoo DJ. Administration of glutamate into the spinal cord at extracellular concentrations reached post-injury causes functional

[14] Bareyre FM, Schwab ME. Inflammation, degeneration and regeneration in the injured spinal cord: Insights from DNA microarrays. Trends in Neurosciences. 2003;26(10):555-563

[15] Ronaghi M, Erceg S, Moreno-Manzano V, Stojkovic M. Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or

[16] Hall ED, Traystman RJ. Role of animal studies in the design of clinical trials. In: Clinical Trials in the Neurosciences. Basel, Switzerland: Karger Publishers; 2009. pp. 10-33 [17] Gris P, Tighe A, Levin D, Sharma R, Brown A. Transcriptional regulation of scar gene

[18] Beattie MS, Farooqui AA, Bresnahan JC. Review of current evidence for apoptosis after

[19] Sullivan PG, Krishnamurthy S, Patel SP, Pandya JD, Rabchevsky AG. Temporal characterization of mitochondrial bioenergetics after spinal cord injury. Journal of Neurotrauma.

[20] Wang X, de Rivero Vaccari JP, Wang H, Diaz P, German R, Marcillo AE, et al. Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury. Journal of Neurotrauma. 2012;29(5):936-945 [21] Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clinical Neuropharmacology.

[22] Esposito E, Paterniti I, Mazzon E, Genovese T, Galuppo M, Meli R, et al. MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord

SCI Statistical Center; 2016

Journal of Neurotrauma. 2003;20(10):1017-1027

impairments. Neuroscience Letters. 2005;384(3):271-276

induced pluripotent stem cells? Stem Cells. 2010;28(1):93-99

expression in primary astrocytes. Glia. 2007;55(11):1145-1155

spinal cord injury. Journal of Neurotrauma. 2000;17(10):915-925

Focus. 2008;25(5):E2

2007;24(6):991-999

2001;24(5):254-264

trauma. BMC Neuroscience. 2011;12(1):31

\*Address all correspondence to: wramadhan@kau.edu.sa

1 PK-Neurooncology Research Group, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan

2 Department of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

3 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

4 Embryonic Stem Cell Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

5 Institute of Biotechnology and Genetic Engineering, University of Agriculture, Peshawar, Pakistan

